Mr. Dahl is currently a private investor, focusing on the healthcare industry.  Previously, he was the co-founder and  Chief Operating Officer of Arrowhawk Capital Partners, an investment company and the Vice President of Strategic Business Development and Vice Chairman of the Board of Directors of Golden Pond Healthcare, Inc.  From April 1999 until June 2006, Mr. Dahl served as the head of Global Healthcare for the Carlyle Group, a leading private equity firm, where he was responsible for the firm's investments in the healthcare field. Prior to Carlyle, Mr. Dahl served as co-head of healthcare investment banking in North America at Credit Suisse First Boston. Mr. Dahl is a director of several private companies.   He is also a member of the Board of Trustees of the Cancer Research Institute.  Mr. Dahl received a BA from Middlebury College and an MBA from the Harvard  Business School.